nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.0665	0.071	CcSEcCtD
Tolazamide—Gliclazide—VEGFA—head and neck cancer	0.0629	1	CrCbGaD
Tolazamide—Eruption—Hydroxyurea—head and neck cancer	0.0573	0.0612	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Docetaxel—head and neck cancer	0.0549	0.0586	CcSEcCtD
Tolazamide—Digestion impaired—Hydroxyurea—head and neck cancer	0.0528	0.0563	CcSEcCtD
Tolazamide—Heartburn—Fluorouracil—head and neck cancer	0.0369	0.0394	CcSEcCtD
Tolazamide—Eruption—Docetaxel—head and neck cancer	0.0298	0.0318	CcSEcCtD
Tolazamide—Heartburn—Docetaxel—head and neck cancer	0.0266	0.0284	CcSEcCtD
Tolazamide—Pancytopenia—Vinblastine—head and neck cancer	0.023	0.0246	CcSEcCtD
Tolazamide—Pancytopenia—Hydroxyurea—head and neck cancer	0.021	0.0224	CcSEcCtD
Tolazamide—Agranulocytosis—Vinblastine—head and neck cancer	0.0202	0.0215	CcSEcCtD
Tolazamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.0157	0.0167	CcSEcCtD
Tolazamide—Erythema—Hydroxyurea—head and neck cancer	0.0154	0.0165	CcSEcCtD
Tolazamide—Malaise—Vinblastine—head and neck cancer	0.0152	0.0163	CcSEcCtD
Tolazamide—Vertigo—Vinblastine—head and neck cancer	0.0152	0.0162	CcSEcCtD
Tolazamide—Leukopenia—Vinblastine—head and neck cancer	0.0151	0.0161	CcSEcCtD
Tolazamide—Pancytopenia—Fluorouracil—head and neck cancer	0.0151	0.0161	CcSEcCtD
Tolazamide—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0145	0.0155	CcSEcCtD
Tolazamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0143	0.0153	CcSEcCtD
Tolazamide—Discomfort—Vinblastine—head and neck cancer	0.0142	0.0152	CcSEcCtD
Tolazamide—Malaise—Hydroxyurea—head and neck cancer	0.0139	0.0148	CcSEcCtD
Tolazamide—Leukopenia—Hydroxyurea—head and neck cancer	0.0138	0.0147	CcSEcCtD
Tolazamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.0135	0.0144	CcSEcCtD
Tolazamide—Hyponatraemia—Docetaxel—head and neck cancer	0.0134	0.0142	CcSEcCtD
Tolazamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.0133	0.0141	CcSEcCtD
Tolazamide—Discomfort—Hydroxyurea—head and neck cancer	0.013	0.0138	CcSEcCtD
Tolazamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0123	0.0131	CcSEcCtD
Tolazamide—Feeling abnormal—Vinblastine—head and neck cancer	0.0114	0.0121	CcSEcCtD
Tolazamide—Erythema—Fluorouracil—head and neck cancer	0.0111	0.0118	CcSEcCtD
Tolazamide—Dyspepsia—Hydroxyurea—head and neck cancer	0.0111	0.0118	CcSEcCtD
Tolazamide—Pancytopenia—Docetaxel—head and neck cancer	0.0109	0.0116	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0109	0.0116	CcSEcCtD
Tolazamide—Fatigue—Hydroxyurea—head and neck cancer	0.0108	0.0116	CcSEcCtD
Tolazamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0104	0.0111	CcSEcCtD
Tolazamide—Leukopenia—Fluorouracil—head and neck cancer	0.00993	0.0106	CcSEcCtD
Tolazamide—Asthenia—Vinblastine—head and neck cancer	0.0099	0.0106	CcSEcCtD
Tolazamide—Agranulocytosis—Docetaxel—head and neck cancer	0.00956	0.0102	CcSEcCtD
Tolazamide—Discomfort—Fluorouracil—head and neck cancer	0.00933	0.00996	CcSEcCtD
Tolazamide—Dizziness—Vinblastine—head and neck cancer	0.00912	0.00974	CcSEcCtD
Tolazamide—Asthenia—Hydroxyurea—head and neck cancer	0.00903	0.00963	CcSEcCtD
Tolazamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00887	0.00946	CcSEcCtD
Tolazamide—Headache—Vinblastine—head and neck cancer	0.00864	0.00922	CcSEcCtD
Tolazamide—Dizziness—Hydroxyurea—head and neck cancer	0.00832	0.00888	CcSEcCtD
Tolazamide—Nausea—Vinblastine—head and neck cancer	0.0082	0.00875	CcSEcCtD
Tolazamide—Erythema—Docetaxel—head and neck cancer	0.00801	0.00855	CcSEcCtD
Tolazamide—Dyspepsia—Fluorouracil—head and neck cancer	0.00797	0.00851	CcSEcCtD
Tolazamide—Rash—Hydroxyurea—head and neck cancer	0.00793	0.00847	CcSEcCtD
Tolazamide—Headache—Hydroxyurea—head and neck cancer	0.00788	0.00841	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00782	0.00834	CcSEcCtD
Tolazamide—Nausea—Hydroxyurea—head and neck cancer	0.00747	0.00798	CcSEcCtD
Tolazamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00746	0.00796	CcSEcCtD
Tolazamide—Urticaria—Fluorouracil—head and neck cancer	0.00719	0.00768	CcSEcCtD
Tolazamide—Leukopenia—Docetaxel—head and neck cancer	0.00717	0.00765	CcSEcCtD
Tolazamide—Pruritus—Fluorouracil—head and neck cancer	0.00641	0.00684	CcSEcCtD
Tolazamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.0064	0.00683	CcSEcCtD
Tolazamide—Dizziness—Fluorouracil—head and neck cancer	0.00599	0.00639	CcSEcCtD
Tolazamide—Dyspepsia—Docetaxel—head and neck cancer	0.00575	0.00614	CcSEcCtD
Tolazamide—Rash—Fluorouracil—head and neck cancer	0.00571	0.00609	CcSEcCtD
Tolazamide—Headache—Fluorouracil—head and neck cancer	0.00567	0.00605	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00564	0.00602	CcSEcCtD
Tolazamide—Fatigue—Docetaxel—head and neck cancer	0.00564	0.00601	CcSEcCtD
Tolazamide—Feeling abnormal—Docetaxel—head and neck cancer	0.00539	0.00575	CcSEcCtD
Tolazamide—Nausea—Fluorouracil—head and neck cancer	0.00538	0.00574	CcSEcCtD
Tolazamide—Asthenia—Docetaxel—head and neck cancer	0.00469	0.005	CcSEcCtD
Tolazamide—Pruritus—Docetaxel—head and neck cancer	0.00462	0.00494	CcSEcCtD
Tolazamide—Dizziness—Docetaxel—head and neck cancer	0.00432	0.00461	CcSEcCtD
Tolazamide—Rash—Docetaxel—head and neck cancer	0.00412	0.0044	CcSEcCtD
Tolazamide—Headache—Docetaxel—head and neck cancer	0.0041	0.00437	CcSEcCtD
Tolazamide—Nausea—Docetaxel—head and neck cancer	0.00388	0.00414	CcSEcCtD
